Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells 'off the shelf'?

被引：31
|
作者：
DiNofia, Amanda M. [1 ,2 ]
Grupp, Stephan A. [1 ,2 ]
机构：
[1] Childrens Hosp Philadelphia, Cellular Therapy & Transplant Sect, Canc Immunotherapy Program, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pediat, Div Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2021年 / 18卷 / 04期
关键词：
D O I：
10.1038/s41571-021-00485-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The question of whether allogeneic chimeric antigen receptor (CAR) T cells could replace autologous CAR T cell therapy has garnered considerable interest, but limited data have been available for comparisons to date. Now, Benjamin et al. have reported their experience with allogeneic anti-CD19 CAR T cells in 21 paediatric and adult patients with acute lymphoblastic leukaemia.
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [21] Off-the-shelf CAR T cells to treat cancer
    Castelli, Sofia
    Young, Regina M.
    June, Carl H.
    CELL RESEARCH, 2022, 32 (12) : 1036 - 1037
  • [22] CAR T cells take to the airways
    Bordon, Yvonne
    NATURE REVIEWS IMMUNOLOGY, 2024, 24 (07) : 457 - 457
  • [23] CAR T cells take to the airways
    Bordon, Yvonne
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (08) : 579 - 579
  • [24] CAR T cells for hematological malignancies
    Savoldo, Barbara
    Grover, Natalie
    Dotti, Gianpietro
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (02):
  • [25] Recent updates on allogeneic CAR-T cells in hematological malignancies
    Mansoori, Shafieeh
    Noei, Ahmad
    Maali, Amirhosein
    Seyed-Motahari, Seyedeh Sheila
    Sharifzadeh, Zahra
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [26] CD28 CAR T Cells for the Treatment of T Cell Malignancies
    Willier, Semjon
    Farber, Julian
    Ispyrlidou, Theodora
    Stenger, Dana
    Nikolaides, Sophia L. M.
    Ernst, Paulina Ferrada
    Peters, Annika E.
    Wilhelm, Jonas
    Stoll, Nadine
    Breidenbach, Maike
    Becker-Dettling, Fiona Ag
    Blaeschke, Franziska
    Kaeuferle, Theresa
    Yassin, Abdallah A. H. A.
    Klein, Christoph
    Feuchtinger, Tobias
    BLOOD, 2023, 142
  • [27] Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cells Malignancies
    Chu, Fuliang
    Weng, Jinsheng
    Kuang, Shao-Qing
    Cheng, Xiaoyun
    Cao, JingJing
    Liu, Jingwei
    Karri, Swathi
    Reddy, Adithi
    Neelapu, Sattva S.
    BLOOD, 2018, 132
  • [28] ALLOGENEIC "OFF-THE-SHELF" γδ T CELLS MODIFIED WITH CD27-CONTAINING CAR FOR TARGETING CD70+CANCERS
    Lamture, Gauri
    Teague, Alexander
    Smith-Boeck, Morgan
    Salum, Michael
    Kaur, Ramandeep
    Gundurao, Smitha
    Parthasarathy, Pannaga
    Chanthery, Yvan
    Herrman, Marissa
    Aftab, Blake
    Bhat, Arun
    Nishimoto, Kevin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A261 - A261
  • [29] Multiple myeloma: soon CAR-T cells off the shelf?
    不详
    TRANSFUSIONSMEDIZIN, 2023, 13 (03) : 114 - 115
  • [30] CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED EPSTEIN-BARR VIRUS (EBV) SPECIFIC T CELLS - AN OFF-THE-SHELF, ALLOGENEIC CAR T-CELL IMMUNOTHERAPY PLATFORM
    Shen, R. R.
    Pham, C. D.
    Wu, M.
    Munson, D. J.
    Aftab, B. T.
    CYTOTHERAPY, 2019, 21 (05) : S11 - S11
12345